WebInterstitial lung disease (ILD) may be associated with systemic inflammatory disorders and autoantibody production. The development of ILD has been described in detail in patients with polymyositis and dermatomyositis,1 – 10 and has been shown to increase morbidity and mortality in patients with myositis.11 – 15 Anti-synthetase antibodies, including anti … http://mdedge.ma1.medscape.com/dermatology/article/145236/rare-diseases/amyopathic-dermatomyositis-plantar-keratoderma-responding/page/0/1
KL-6 as a biomarker of interstitial lung disease JIR
WebApr 3, 2013 · Myositis was closely associated with ... (ILD) was correlated with all 6 anti-ARS Abs. Dermatomyositis (DM)-specific skin manifestations (heliotrope rash and Gottron's sign) were frequently observed in patients with anti-Jo-1, anti-EJ, anti-PL-7, and anti-PL-12. Therefore, most clinical diagnoses were polymyositis or DM for anti ... WebDec 14, 2024 · Some patients with interstitial lung diseases (ILDs) other than idiopathic pulmonary fibrosis exhibit a progressive clinical phenotype. These chronic progressive fibrosing ILDs have a variety of underlying diseases, and their prevalence is currently unknown. Here we carry out the first systematic review of literature on the prevalence of … flared bolt carrier
Full article: Remarkable benefits of intravenous immunoglobulin …
WebJun 22, 2024 · The efficacy of azathioprine (AZA) and mycophenolate mofetil (MMF) for interstitial lung disease (ILD) has been described, but mainly in connective tissue disease-associated ILD. The objective of this study was to evaluate the effect of AZA and MMF on lung function and prednisone dose in myositis-related ILD (M-ILD). WebMay 8, 2024 · Purpose of review Describe the treatment of antisynthetase syndrome-associated interstitial lung disease (AS-ILD). Recent findings The pathogenesis of AS-ILD involves the abnormal activation of the innate and adaptive immune systems, including activation of NK cells, dendritic cells, T-cells, and B-cells. Immunosuppressive agents … WebDermatomyositis (DM) and polymyositis (PM) are debilitating inflammatory myopathies characterized by the subacute onset of symmetric proximal muscle weakness (1). DM/PM are associated with considerable mortality, with ten-year survival most recently estimated to be 53–91% (2–5). flared bottom coffee cups